ACRS Earnings

Quarterly EPS
$-0.11
Q3 2024
$-1.01
Q4 2024
$-0.12
Q1 2025
$-0.13
Q2 2025
$-0.12
Q3 2025
$-0.16
Q4 2025
$-0.15
Q1 2026
$-0.15
Q2 2026
Latest Revenue1.6M
Latest Net Income-21505000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.151.6M-21505000-8.3%-15.4%
Q1 2026-$0.152.0M-19824000+37.2%-25.0%
Q4 2025-$0.161.3M-19795000-85.9%+84.2%
Q3 2025-$0.123.3M-14614000-24.1%-9.1%
Q2 2025-$0.131.8M-15429000-35.8%+13.3%
Q1 2025-$0.121.5M-15085000-39.3%+50.0%
Q4 2024-$1.019.2M-96552000-47.6%-4,950.0%
Q3 2024-$0.114.3M-7586000-53.2%+73.2%
Q2 2024-$0.152.8M-10986000
Q1 2024-$0.242.4M-16941000
Q4 2023-$0.0217.6M-1491000
Q3 2023-$0.419.3M-29261000
Aclaris Therapeutics (ACRS) — Earnings